Watch These UnitedHealth Price Levels as Stock Jumps After Buffett's Berkshire Reveals Stake

UnitedHealth Group (UNH) shares surged over 11% on Friday, boosting the Dow, after Warren Buffett’s Berkshire Hathaway revealed a new stake in the healthcare giant. This significant rally follows a year-to-date decline of over a third for UNH, driven by concerns over Medicare billing practices and rising care costs. Technically, the stock broke above a steep downtrend line, with key overhead resistance levels identified at $325, $380, and $440, while a critical support zone is noted between $250 and $235.

Analysis

UnitedHealth Group (UNH) experienced a significant rally, with shares surging over 11% on Friday following the disclosure of a new stake by Warren Buffett’s Berkshire Hathaway, a move that also helped lift the Dow Jones Industrial Average. This strong positive momentum represents a notable reversal for the healthcare giant, which had previously shed over a third of its value year-to-date. The stock's prior weakness was attributed to significant fundamental headwinds, including investigations into its Medicare billing practices, the sudden departure of its former CEO in May, and a downbeat forecast driven by higher care costs. From a technical perspective, the stock's recovery is marked by a breakout above a steep downtrend line extending from its April peak, a move corroborated by the Relative Strength Index (RSI) rising above its neutral threshold, indicating accelerating buying interest. Key overhead resistance levels are now identified at $325, $380, and $440, while a critical support zone is established between $250 and $235, corresponding to the May and August troughs.

Key Decisions for Investors

• Given Berkshire Hathaway's new position and the technical breakout above a key downtrend line, the stock now has a renewed positive catalyst and improved short-term momentum.
• Investors should remain cognizant of the unresolved fundamental headwinds, including investigations into Medicare billing and the impact of higher care costs, which previously drove the stock's significant year-to-date decline.
• Traders should closely monitor the identified resistance levels at $325, $380, and $440 for potential profit-taking or signs of reversal, while the $250-$235 support zone could present a strategic entry point during any pullbacks.